drugset / Trial / NCT07170462

Cranberry and Gut Health in Crohn's Disease

NCT07170462 ↗

Phase 0 Recruiting 50 enrolled Ana Maldonado-Contreras
RandomizedParallel-groupQuadruple-blindBasic science

Summary

This study is investigating whether a cranberry-based dietary supplement, rich in polyphenols and fiber, can enhance gut health in individuals with Crohn's disease. People with Crohn's disease often have an imbalance in their gut microbiome (the community of bacteria in the gut). Previous research suggests that cranberry compounds may help support beneficial gut bacteria. In this study, adults with Crohn's disease will be randomly assigned to one of two groups: one group will receive a cranberry supplement to take once daily for 10 weeks, and the other group will receive a placebo (a supplement with no active ingredients). All participants will be asked to complete online questionnaires and collect samples of their blood, urine, and stool at four time points over a total of 15 weeks. These samples will help researchers understand how the cranberry supplement affects the gut microbiome, inflammation, and overall health. Participation is voluntary, and participants can withdraw from the study at any time. The results of this study may help identify new diet-based approaches to improve gut health in individuals with Crohn's disease.

Timeline

Start
2025-10-29
Primary completion
2026-08-15
Completion
2026-08-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Cranberry powder Unknown 100 g —

Indications